Injectable hydromorphone now approved to treat opioid addiction
Canada is the first country to approve the pain drug for severe opioid use disorder, a result of research led by CHÉOS and PHC scientists and staff.
Read MoreCanada is the first country to approve the pain drug for severe opioid use disorder, a result of research led by CHÉOS and PHC scientists and staff.
Read MoreDr. Annalijn Conklin is leading a new project, funded by a CIHR Catalyst Grant and using data from the Canadian Longitudinal Study on Aging
Read MoreRenewed as a Canada Research Chair in Patient-Centered Outcomes, Dr. Rick Sawatzky looks to change the way some data are collected and interpreted.
Read MoreCHÉOS Scientists are leading three of the projects funded through this round of the competition and a further seven projects are supported by CHÉOS Scientists as co-investigators.
Read MoreCHÉOS Scientist Dr. Sarah Munro is leading a study to evaluate the use of video documentary as a means of knowledge translation (KT) related to microbes and early childhood development.
Read MoreCHÉOS Scientists lead a number of Methods Clusters and projects with the BC SUPPORT Unit.
Read More